Latest Breaking News On - Colorado denver anschutz medical center - Page 1 : comparemela.com

​​​​​​​The Phase II study, conducted in the Netherlands, evaluated the single-dose ANEB-001 in treating healthy participants affected by THC. Anebulo plans to file an IND with the FDA by the end of 2022.

United statesAndrew monteSimon allenAnebulo pharmaceuticalsAnschutz medical centerCannabis researchDrug administration modelDrug developmentCentre for human drug researchUniversity of colorado denverHuman drug researchEmergency medicineMedical toxicologyColorado denver anschutz medical centerDrug administrationModel informed drug development